Equities

Genus PLC

GNS:LSE

Genus PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)3,035.00
  • Today's Change5.00 / 0.17%
  • Shares traded66.48k
  • 1 Year change67.31%
  • Beta1.3960
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2025202520242023
REVENUE AND GROSS PROFIT
Total revenue673669690
OPERATING EXPENSES
Cost of revenue total455----
Selling, general and admin. expenses, total1237.006.00
Depreciation/amortization115.807.70
Unusual expense(income)304820
Other operating expenses, total--602615
Total operating expense634662649
Operating income396.4041
Other, net(1)(0.3)1.90
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes295.5039
Provision for income taxes9.203.107.60
Net income after taxes192.4032
Minority interest05.501.50
Net income before extra. Items197.9033
Total extraordinary items------
Net income197.9033
Inc.avail. to common excl. extra. Items197.9033
Inc.avail. to common incl. extra. Items197.9033
EPS RECONCILIATION
Basic/primary weighted average shares666666
Basic/primary eps excl. extra items0.290.120.51
Basic/primary eps incl. extra items0.290.120.51
Dilution adjustment------
Diluted weighted average shares676666
Diluted eps excl. extra items0.290.120.50
Diluted eps incl. extra items0.290.120.50
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.320.320.32
Gross dividend - common stock--2121
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental202215
SUPPLEMENTAL INCOME
Depreciation, supplemental323530
Total special items305020
NORMALISED INCOME
Normalized income before taxes595560
Effect of special items on income taxes9.72283.94
Income tax excluding impact of special items193112
Normalized income after tax402448
Normalized income avail. to common403050
Basic normalized EPS0.600.450.76
Diluted normalized EPS0.590.450.75
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.